# FDA Inspection 1136279 - Albireo Pharma, Inc. - February 16, 2021

Source: https://www.keypedia.com/records/fda_inspections/albireo-pharma-inc/6fe4c9bd-a825-4253-a1df-3d16861753ca
Source feed: FDA_Inspections

> FDA Inspection 1136279 for Albireo Pharma, Inc. on February 16, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1136279
- Company Name: Albireo Pharma, Inc.
- Inspection Date: 2021-02-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1228829 - 2023-12-07](https://www.keypedia.com/records/fda_inspections/albireo-pharma-inc/3f50c1a0-ed3b-4014-9480-2c7fd07ec45d)

Company: https://www.keypedia.com/companies/albireo-pharma-inc/8c0997c8-d56a-40da-986e-db93f08194d6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c